Analysis of Genome-Wide Association Studies of Alzheimer Disease and of Parkinson Disease to Determine If These 2 Diseases Share a Common Genetic Risk
Year: 2013
Type: article
Abstract: IMPORTANCE: Despite Alzheimer disease (AD) and Parkinson disease (PD) being clinically distinct entities, there is a possibility of a pathological overlap, with some genome-wide association (GWA) studies suggesting that the 2 diseases represent a biological continuum. The application of GWA studies to idiopathic forms of AD and PD have identified a number of loci that contain genetic variants that increase the risk of these disorders. OBJECTIVE: To assess the genetic overlap between PD and AD by testing for the presence of potentially pleiotropic loci in 2 recent GWA studies of PD and AD. DESIGN: Combined GWA analysis. SETTING: Data sets from the United Kingdom, Germany, France, and the United States. PARTICIPANTS: Thousands of patients with AD or PD and their controls. MAIN OUTCOMES AND MEASURES: Meta-analysis of GWA studies of AD and PD. METHODS: To identify evidence for potentially pleiotropic alleles that increased the risk for both PD and AD, we performed a combined PD-AD meta-analysis and compared the results with those obtained in the primary GWA studies.We also tested for a net effect of potentially polygenic alleles that were shared by both disorders by performing a polygenic score analysis. Finally, we also performed a gene-based association analysis that was aimed at detecting genes that harbor multiple disease-causing single-nucleotide polymorphisms, some of which confer a risk of PD and some a risk of AD. RESULTS: Detailed interrogation of the single-nucleotide polymorphism, polygenic, and gene-based analyses resulted in no significant evidence that supported the presence of loci that increase the risk of both PD and AD. CONCLUSIONS AND RELEVANCE: Our findings therefore imply that loci that increase the risk of both PD and AD are not widespread and that the pathological overlap could instead be “downstream” of the primary susceptibility genes that increase the risk of each disease.
Source: JAMA Neurology
Authors: Valentina Moskvina, Denise Harold, GianCarlo Russo, Alexey Vedernikov, Manu Sharma, Mohamed Saad, Peter Holmans, Jose M Bras, Francesco Bettella, Margaux F Keller, Nayia Nicolaou, Javier Simón-Sánchez, J Raphael Gibbs, Claudia Schulte, Alexandra Durr, Rita Guerreiro, Dena Hernandez, Alexis Brice, Hreinn Stefánsson, Kari Majamaa, Thomas Gasser, Peter Heutink, Nick Wood, Maria Martinez, Andrew B Singleton, Michael A Nalls, John Hardy, Michael J Owen, Michael C O'Donovan, Julie Williams, Huw R Morris, Nigel M Williams
Institutions: Cardiff University, Hertie Institute for Clinical Brain Research, University of Tübingen, Université Toulouse III - Paul Sabatier, Inserm, Centre de Physiopathologie de Toulouse-Purpan, Institut Toulousain des Maladies Infectieuses et Inflammatoires, UCL Queen Square Institute of Neurology, University College London, deCODE Genetics (Iceland), National Institutes of Health, National Institute on Aging, Amsterdam UMC Location Vrije Universiteit Amsterdam, German Center for Neurodegenerative Diseases, Institut du Cerveau, Université Pierre-et-Marie-Curie, University of Oulu
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: Genome wide SNP analysis in Parkinson's disease, G3327757157, Identification of new genes causing familial forms of PD, Further defining the genetic architecture of Alzheimer's disease, G4218389, ERANET 1 NEURON 3: Identification of copy number variants in familial and pathologically proven PD, Genetic Analysis Of Alzheimer s Disease, Mentorship Program Patient-Oriented Research on Aging, G7423759087, G7433172200, Identification of copy number variants in familial and pathologically proven PD, Genome wide SNP analysis in Parkinson's disease
OpenAlex ID: W2147315853
